About this episode

Dr. J. Silvio Gutkind sheds light on his work and life since the beginning of COVID restrictions. A large component of his work is centered around dysregulated signaling in cancer and the development of novel mechanism-based cancer therapies. In this episode, Dr. J. Silvio Gutkind highlights how his past experience proves useful in current COVID times and potential benefits the changes in work environments can do for future collaborations.

Dr. J. Silvio Gutkind on the web

• Gutkind Lab – UC San Diego Moores Cancer Center

• Gutkind Lab publications

• More Publications from the Gutkind Lab on Pubmed

• Dr. J Silvio Gutkind on LinkedIn

• Gutkind Lab on Twitter

• UCSD Moores Cancer Center

• Dr. GPCR Ecosystem